- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Increased IL-17A levels linked to increased prior surgery for chronic rhinosinusitis: Study
USA: Higher IL-17A levels is associated with an increased number of prior sinus surgeries for chronic rhinosinusitis (CRS), finds a recent study in the International Forum of Allergy & Rhinology. The findings show that the presence of type 3 inflammatory markers may be indicative of a particularly difficult‐to‐treat, recalcitrant CRS endotype.
The identification of potential inflammatory endotypes of CRS have been possible due to the recent advances in molecular biology. Prior work has suggested differential short‐term surgical outcome trajectories based on cytokine signatures. However, there is a lack of data assessing long‐term treatment failure and need for revision surgery based on inflammatory biomarkers. To determine the same, Nikita Chapurin, Vanderbilt University Medical Center, Nashville, TN, USA, and colleagues performed a retrospective analysis of prospectively collected cross‐sectional data from 231 patients electing surgical therapy for CRS.
The researchers quantitatively sampled intraoperative mucus specimens for inflammatory cytokines using a multiplex flow cytometric bead assay. Univariate Spearman correlations between cytokine levels and prior number of surgeries were assessed. Patient‐reported prior sinus surgery counts as a function of cytokine levels was modeled using a stepwise adjusted multivariate Poisson regression analysis.
Key findings of the study include:
- Several cytokines (interleukin [IL]‐1β, IL‐4, IL‐5, IL‐6, IL‐8, IL‐10, IL‐13, IL‐17A, tumor necrosis factor α [TNF‐α], interferon γ [IFN‐γ], and eotaxin) demonstrated significant positive correlations with number of prior surgeries.
- Only higher IL‐17A levels were independently associated with a higher number of prior sinus surgeries (β = 0.345) after adjusting for the significant covariates of age (β = 0.018), Lund‐Mackay score (β = –0.046), history of aspirin‐exacerbated respiratory disease (β = 1.01) and allergic fungal rhinosinusitis (β = 1.08).
- Higher levels of regulated on activation, normal T‐cell expressed and secreted (RANTES) were conversely associated with a lower number of prior surgeries (β = –0.17)
"An IL‐17A–predominant cytokine profile is linked to an increased number of prior sinus surgeries. Thus, type 3 inflammatory markers may indicate a particularly difficult‐to‐treat, recalcitrant CRS endotype," wrote the authors.
The study titled, "Elevated mucus interleukin‐17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis," is published in the journal International Forum of Allergy & Rhinology.
DOI: https://onlinelibrary.wiley.com/doi/abs/10.1002/alr.22652
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751